Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock?

Group 1 - The stock of Amphastar Pharmaceuticals, Inc. (AMPH) is experiencing significant attention due to high implied volatility in the options market, particularly the June 20, 2025 $65 Call option [1] - Implied volatility indicates the market's expectation of future price movement, suggesting that investors anticipate a significant price change or an upcoming event that could impact the stock [2] - Amphastar currently holds a Zacks Rank 3 (Hold) in the Medical - Generic Drugs industry, which is in the top 20% of the Zacks Industry Rank, indicating a relatively stable outlook [3] Group 2 - Over the past 60 days, there has been a mixed sentiment among analysts regarding Amphastar's earnings estimates, with one analyst increasing estimates while two have decreased them, leading to a consensus estimate drop from 70 cents to 66 cents per share [3] - The high implied volatility may present trading opportunities, as options traders often seek to sell premium on options with high implied volatility, aiming to benefit from the decay of options value [4]